Table 3 Past experience with acute medication for migraine
10–29 | 30–39 | 40–49 | 50–59 | 60 + | Overall – all age groups combined | |
|---|---|---|---|---|---|---|
Variable | ||||||
Number of patients, N (% of total patients) | 25 (12.1%) | 40 (19.3%) | 63 (30.4%) | 47 (22.7%) | 32 (15.5%) | 207 (100%) |
Satisfaction with acute medicationa, n (% of age group) | ||||||
Overall | 3 (12.0) | 12 (30.0) | 17 (27.0) | 11 (23.4) | 13 (40.6) | 56 (27.1) |
Free of headache within 2 h | 6 (24.0) | 21 (52.5) | 21 (33.3) | 23 (48.9) | 17 (53.1) | 88 (42.5) |
Free of accompanying symptoms within 2 h | 6 (24.0) | 18 (45.0) | 22 (34.9) | 24 (51.1) | 17 (53.1) | 87 (42.0) |
24-h sustained effect | 6 (24.0) | 14 (35.0) | 19 (30.2) | 17 (36.2) | 13 (40.6) | 69 (33.3) |
Feel burden of cost | 6 (24.0) | 10 (25.0) | 17 (27.0) | 12 (25.5) | 4 (12.5) | 49 (23.7) |